Price $28.37 |
Market Cap
313.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
27.1
|
P/B
2.75
|
P/S
1.19
|
Dividend %
-
|
|
P/CF
11.3
|
P/FCF
10.3
|
Op. Cash Flow
31.2K
|
FCF
2.8
|
|
Op. Margin
6.60%
|
Net Margin
10.00%
|
ROE
24.40%
|
ROI
9.70%
|
|
ROA
16.90%
|
EPS Growth
-
|
Current Ratio
2.2
|
Debt/Equity
17.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Uroplasty, Inc. (UPI) | $3.74 | - | - | 89.1M | Strong Buy |
| Sunwin Stevia International In (SUWN) | $0.10 | - | - | 14.8M | Strong Buy |
| Hasco Medical Inc (HASC) | $0.02 | - | - | 19.8M | Strong Buy |
| Arrhythmia Research Technology (HRT) | $5.35 | - | - | 12.5M | Strong Buy |
| Merus Labs International Inc ( (MSLI) | $1.72 | - | - | 63.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
